Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 3
1963 1
1964 1
1979 5
1980 4
1981 8
1982 10
1983 8
1984 14
1985 13
1986 22
1987 17
1988 26
1989 31
1990 24
1991 31
1992 24
1993 20
1994 40
1995 50
1996 43
1997 56
1998 57
1999 74
2000 78
2001 90
2002 122
2003 142
2004 167
2005 190
2006 259
2007 307
2008 340
2009 378
2010 398
2011 505
2012 569
2013 668
2014 830
2015 973
2016 1021
2017 1141
2018 1358
2019 1525
2020 1878
2021 2190
2022 2586
2023 2622
2024 504

Text availability

Article attribute

Article type

Publication date

Search Results

19,114 results

Results by year

Filters applied: . Clear all
Page 1
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
Mai HQ, Chen QY, Chen D, Hu C, Yang K, Wen J, Li J, Shi Y, Jin F, Xu R, Pan J, Qu S, Li P, Hu C, Liu YC, Jiang Y, He X, Wang HM, Lim WT, Liao W, He X, Chen X, Wang S, Yuan X, Li Q, Lin X, Jing S, Chen Y, Lu Y, Hsieh CY, Yang MH, Yen CJ, Samol J, Luo X, Wang X, Tang X, Feng H, Yao S, Keegan P, Xu RH. Mai HQ, et al. Among authors: tang x. JAMA. 2023 Nov 28;330(20):1961-1970. doi: 10.1001/jama.2023.20181. JAMA. 2023. PMID: 38015220 Clinical Trial.
Pan-cancer proteogenomics characterization of tumor immunity.
Petralia F, Ma W, Yaron TM, Caruso FP, Tignor N, Wang JM, Charytonowicz D, Johnson JL, Huntsman EM, Marino GB, Calinawan A, Evangelista JE, Selvan ME, Chowdhury S, Rykunov D, Krek A, Song X, Turhan B, Christianson KE, Lewis DA, Deng EZ, Clarke DJB, Whiteaker JR, Kennedy JJ, Zhao L, Segura RL, Batra H, Raso MG, Parra ER, Soundararajan R, Tang X, Li Y, Yi X, Satpathy S, Wang Y, Wiznerowicz M, González-Robles TJ, Iavarone A, Gosline SJC, Reva B, Robles AI, Nesvizhskii AI, Mani DR, Gillette MA, Klein RJ, Cieslik M, Zhang B, Paulovich AG, Sebra R, Gümüş ZH, Hostetter G, Fenyö D, Omenn GS, Cantley LC, Ma'ayan A, Lazar AJ, Ceccarelli M, Wang P; Clinical Proteomic Tumor Analysis Consortium. Petralia F, et al. Among authors: tang x. Cell. 2024 Feb 12:S0092-8674(24)00064-3. doi: 10.1016/j.cell.2024.01.027. Online ahead of print. Cell. 2024. PMID: 38359819
[Advances in nanobody screening technology].
Tang X, Deng A, Chen W, Zhao Y, Wang M, Li C. Tang X, et al. Sheng Wu Gong Cheng Xue Bao. 2024 Feb 25;40(2):350-366. doi: 10.13345/j.cjb.230472. Sheng Wu Gong Cheng Xue Bao. 2024. PMID: 38369826 Review. Chinese.
Epigenetic regulations of cellular senescence in osteoporosis.
Huo S, Tang X, Chen W, Gan D, Guo H, Yao Q, Liao R, Huang T, Wu J, Yang J, Xiao G, Han X. Huo S, et al. Among authors: tang x. Ageing Res Rev. 2024 Feb 15:102235. doi: 10.1016/j.arr.2024.102235. Online ahead of print. Ageing Res Rev. 2024. PMID: 38367814 Review.
The LMIT: Light-mediated minimally-invasive theranostics in oncology.
Fan Y, Liu S, Gao E, Guo R, Dong G, Li Y, Gao T, Tang X, Liao H. Fan Y, et al. Among authors: tang x. Theranostics. 2024 Jan 1;14(1):341-362. doi: 10.7150/thno.87783. eCollection 2024. Theranostics. 2024. PMID: 38164160 Free PMC article. Review.
Editorial: Diabetes and obesity effects on lung function, volume II.
Zheng H, Ma W, Tang X, Lecube A, Yan LJ. Zheng H, et al. Among authors: tang x. Front Endocrinol (Lausanne). 2023 Dec 7;14:1345489. doi: 10.3389/fendo.2023.1345489. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38144559 Free PMC article. No abstract available.
19,114 results
You have reached the last available page of results. Please see the User Guide for more information.